Literature DB >> 18953568

Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.

J A Schoenhard1, F W Asselbergs, K A Poku, S A Stocki, S Gordon, D E Vaughan, N J Brown, J H Moore, Scott M Williams.   

Abstract

Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) directly influence thrombus formation and degradation, and have been identified as risk factors for thromboembolic disease. Prior studies investigated determinants of t-PA and PAI-1 expression, but mainly in Caucasian subjects. The aim of this study was to identify the contributions of genetic and other factors to inter-individual variation in plasma levels of t-PA and PAI-1 in a large-scale population-based sample from urban West Africa. t-PA, PAI-1 and several demographic, anthropometric, and metabolic parameters were measured in 992 residents of Sunyani, the capital of the Brong-Ahafo region of Ghana. In addition, nine gene polymorphisms associated with components of the renin-angiotensin and fibrinolytic systems were determined. We found that BMI, systolic and diastolic blood pressure, total cholesterol, glucose, and triglycerides were all significant predictors of t-PA and PAI-1 in both females and males. In addition, a significant relationship was found between the PAI-1 4G/5G (rs1799768) polymorphism on PAI-1 levels in females, the TPA I/D (rs4646972) polymorphism on t-PA and PAI-1 in males, the renin (rs3730103) polymorphism on t-PA and PAI-1 in males, the ethanolamine kinase 2 (rs1917542) polymorphism on PAI-1 in males, and the renin (rs1464816) polymorphism on t-PA in females and on PAI-1 in males. This study of urban West Africans shows that t-PA and PAI-1 levels are determined by both genetic loci of the fibrinolytic and renin-angiotensin systems and other factors often associated with cardiovascular disease, and that genetic factors differ between males and females.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953568      PMCID: PMC2770717          DOI: 10.1007/s00439-008-0573-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  44 in total

1.  No adjustments are needed for multiple comparisons.

Authors:  K J Rothman
Journal:  Epidemiology       Date:  1990-01       Impact factor: 4.822

2.  Features of menopause and menopausal age in Nigerian women.

Authors:  F E Okonofua; A Lawal; J K Bamgbose
Journal:  Int J Gynaecol Obstet       Date:  1990-04       Impact factor: 3.561

3.  Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.

Authors:  D J Schneider; B E Sobel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

4.  A population-based study in Ghana to investigate inter-individual variation in plasma t-PA and PAI-1.

Authors:  Scott M Williams; Shelli Stocki; Lan Jiang; Kwabena Brew; Seth Gordon; Douglas E Vaughan; Nancy J Brown; Kwabena A Poku; Jason H Moore
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

Review 5.  Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.

Authors:  T Skurk; H Hauner
Journal:  Int J Obes Relat Metab Disord       Date:  2004-11

6.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event.

Authors:  M Ludwig; K D Wohn; W D Schleuning; K Olek
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

9.  Insulin resistance in essential hypertension.

Authors:  E Ferrannini; G Buzzigoli; R Bonadonna; M A Giorico; M Oleggini; L Graziadei; R Pedrinelli; L Brandi; S Bevilacqua
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

10.  Association between obesity and a prothrombotic state: the Framingham Offspring Study.

Authors:  Guido A Rosito; Ralph B D'Agostino; Joseph Massaro; Izabella Lipinska; Murray A Mittleman; Patrice Sutherland; Peter W F Wilson; Daniel Levy; James E Muller; Geoffrey H Tofler
Journal:  Thromb Haemost       Date:  2004-04       Impact factor: 5.249

View more
  9 in total

Review 1.  Genetic Effects on the Correlation Structure of CVD Risk Factors: Exome-Wide Data From a Ghanaian Population.

Authors:  Nuri Kodaman; Rafal S Sobota; Folkert W Asselbergs; Matthew T Oetjens; Jason H Moore; Nancy J Brown; Melinda C Aldrich; Scott M Williams
Journal:  Glob Heart       Date:  2017-04-10

2.  Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction.

Authors:  Waqas Ahmed; Meera Malik; Imran Saeed; Amina Ali Khan; Ahmed Sadeque; Umar Kaleem; Nuzhat Ahmed; Muhammad Ajmal; Maleeha Azam; Raheel Qamar
Journal:  Mol Biol Rep       Date:  2010-11-17       Impact factor: 2.316

3.  Association between the rs6950982 polymorphism near the SERPINE1 gene and blood pressure and lipid parameters in a high-cardiovascular-risk population: interaction with Mediterranean diet.

Authors:  Mercedes Sotos-Prieto; Marisa Guillén; Olga Portolés; José V Sorlí; José I González; Eva M Asensio; Dolores Corella
Journal:  Genes Nutr       Date:  2012-12-09       Impact factor: 5.523

4.  The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels.

Authors:  Christopher S Coffey; Folkert W Asselbergs; Patricia R Hebert; Hans L Hillege; Qing Li; Jason H Moore; Wiek H van Gilst
Journal:  Cardiol Res Pract       Date:  2011-04-04       Impact factor: 1.866

5.  Epistatic interactions in genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.

Authors:  Nadia M Penrod; Kwabena A Poku; Douglas E Vaughan; Douglas E Vaughn; Folkert W Asselbergs; Nancy J Brown; Jason H Moore; Scott M Williams
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

6.  In black South Africans from rural and urban communities, the 4G/5G PAI-1 polymorphism influences PAI-1 activity, but not plasma clot lysis time.

Authors:  Zelda de Lange; Dingeman C Rijken; Tiny Hoekstra; Karin R Conradie; Johann C Jerling; Marlien Pieters
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

7.  Cardiovascular Disease Risk Factors in Ghana during the Rural-to-Urban Transition: A Cross-Sectional Study.

Authors:  Nuri Kodaman; Melinda C Aldrich; Rafal Sobota; Folkert W Asselbergs; Kwabena A Poku; Nancy J Brown; Jason H Moore; Scott M Williams
Journal:  PLoS One       Date:  2016-10-12       Impact factor: 3.240

8.  Comparable Enhanced Prothrombogenesis in Simple Central Obesity and Metabolic Syndrome.

Authors:  Noor Shafina Mohd Nor; Hanis Saimin; Thuhairah Rahman; Suraya Abdul Razak; Nadzimah Mohd Nasir; Zaliha Ismail; Hapizah Mohd Nawawi
Journal:  J Obes       Date:  2018-03-26

9.  Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population.

Authors:  Marquitta J White; Nuri M Kodaman; Reed H Harder; Folkert W Asselbergs; Douglas E Vaughan; Nancy J Brown; Jason H Moore; Scott M Williams
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.